Literature DB >> 16160814

[Radiological diagnosis of Klatskin's tumour].

S Pauls1, M S Juchems, H-J Brambs.   

Abstract

Patients with Klatskin's tumour present clinically unspecific symptoms such as painless jaundice and cholangitic discomfort. The only curative treatment is R0 resection of the tumour. To allow stage-specific therapy, accurate tumour staging is indispensable, the first step of which is abdominal sonography. If there is a suspect finding, cross-sectional imaging techniques like MRI or MDR-CT are used to clarify or stage the lesion, respectively. To estimate resectability, MRI together with MRC and MRI angiography are superior to MDR-CT. Biopsy using ERC is required before starting any specific treatment. If therapeutically relevant peritoneal carcinosis is clinically suspected although not radiologically confirmed, PET should also be performed. The value of PET/CT has to be evaluated in further studies. For optimal treatment, close cooperation between clinicians and radiologists is necessary.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16160814     DOI: 10.1007/s00117-005-1271-5

Source DB:  PubMed          Journal:  Radiologe        ISSN: 0033-832X            Impact factor:   0.635


  28 in total

1.  Staging, resectability, and outcome in 225 patients with hilar cholangiocarcinoma.

Authors:  W R Jarnagin; Y Fong; R P DeMatteo; M Gonen; E C Burke; J Bodniewicz BS; M Youssef BA; D Klimstra; L H Blumgart
Journal:  Ann Surg       Date:  2001-10       Impact factor: 12.969

2.  Preoperative evaluation of hilar cholangiocarcinoma with contrast-enhanced three-dimensional fast imaging with steady-state precession magnetic resonance angiography: comparison with intraarterial digital subtraction angiography.

Authors:  Moon-Gyu Lee; Kwang Bo Park; Yong Moon Shin; Hyun Ki Yoon; Kyu Bo Sung; Myung Hwan Kim; Sung Gyu Lee; Eun Mee Kang
Journal:  World J Surg       Date:  2003-02-27       Impact factor: 3.352

3.  MR imaging of intrahepatic cholangiocarcinoma: use of ferumoxides for lesion localization and extension.

Authors:  H J Braga; K Imam; D A Bluemke
Journal:  AJR Am J Roentgenol       Date:  2001-07       Impact factor: 3.959

4.  Malignant hilar and perihilar biliary obstruction: use of MR cholangiography to define the extent of biliary ductal involvement and plan percutaneous interventions.

Authors:  J E Lopera; J A Soto; F Múnera
Journal:  Radiology       Date:  2001-07       Impact factor: 11.105

5.  A prospective comparison of the diagnostic accuracy of ERCP, MRCP, CT, and EUS in biliary strictures.

Authors:  Thomas Rösch; Alexander Meining; Silke Frühmorgen; Christian Zillinger; Volker Schusdziarra; Karin Hellerhoff; Meinhard Classen; Hermann Helmberger
Journal:  Gastrointest Endosc       Date:  2002-06       Impact factor: 9.427

6.  Hilar biliary obstruction: preliminary results with Levovist-enhanced sonography.

Authors:  Korosh Khalili; Ur Metser; Stephanie R Wilson
Journal:  AJR Am J Roentgenol       Date:  2003-03       Impact factor: 3.959

7.  Pancreatic malignancy: value of arterial, pancreatic, and hepatic phase imaging with multi-detector row CT.

Authors:  Joel G Fletcher; Maurits J Wiersema; Michael A Farrell; Jeff L Fidler; Lawrence J Burgart; Takashi Koyama; C Daniel Johnson; David H Stephens; Ellen M Ward; W Scott Harmsen
Journal:  Radiology       Date:  2003-10       Impact factor: 11.105

8.  Poor sensitivity of sonography in detection of hepatocellular carcinoma in advanced liver cirrhosis: accuracy of pretransplantation sonography in 118 patients.

Authors:  Wei Chiang Liu; Jae Hoon Lim; Cheol Keun Park; Min Ju Kim; Seung Hoon Kim; Soon Jin Lee; Won Jae Lee; Hyo Keun Lim
Journal:  Eur Radiol       Date:  2003-02-05       Impact factor: 5.315

Review 9.  Magnetic resonance imaging of cholangiocarcinoma.

Authors:  Riccardo Manfredi; Brunella Barbaro; Gabriele Masselli; Amorino Vecchioli; Pasquale Marano
Journal:  Semin Liver Dis       Date:  2004-05       Impact factor: 6.115

10.  Aggressive surgical treatment of intrahepatic cholangiocarcinoma: predictors of outcomes.

Authors:  S Roayaie; J V Guarrera; M Q Ye; S N Thung; S Emre; T M Fishbein; S R Guy; P A Sheiner; C M Miller; M E Schwartz
Journal:  J Am Coll Surg       Date:  1998-10       Impact factor: 6.113

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.